1989PubMedRequires access

[Ivermectin. A new drug against onchocerciasis].

O Otterlei

Open publisher page 0 citations

Abstract

Ivermectin is a new drug for treatment of onchocerciasis. Experimental and clinical studies have shown that ivermectin is effective in the treatment of onchocerciasis when given as a single dose of 150 microgram/kilo bodyweight once a year. Ivermectin is registered as Mectizan and is at present supplied free of charge by Merck Sharp & Dohme for treatment programs in 11 developing countries.

About this research paper

What this paper is about

Ivermectin is a new drug for treatment of onchocerciasis. Experimental and clinical studies have shown that ivermectin is effective in the treatment of onchocerciasis when given as a single dose of 150 microgram/kilo bodyweight once a year. Ivermectin is registered as Mectizan and is at present supplied free of charge by Merck Sharp & Dohme for treatment programs in 11 developing countries.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ivermectin is a new drug for treatment of onchocerciasis. Experimental and clinical studies have shown that ivermectin is effective in the treatment of onchocerciasis when given as a single dose of 150 microgram/kilo bodyweight once a year. Ivermectin is registered as Mectizan and is at present supplied free of charge by Merck Sharp & Dohme for treatment programs in 11 developing countries.

Key concepts: Ivermectin, Onchocerciasis, Onchocerca volvulus, Antiparasitic agent, Drug, Medicine, Pharmacology, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Ivermectin. A new drug against onchocerciasis]. — Research Paper | ScholarLens